Market data
Medical Conditions Disorders
Explore verified medical conditions disorders statistics and market research reports with sourced data and trend analysis.
Latest update:
Elif Demirci
Hemochromatosis Statistics
Untreated C282Y homozygotes face a 20 to 30% lifetime jump to cirrhosis and an annual 2 to 4% risk of hepatocellular carcinoma once cirrhosis is present, yet early phlebotomy can cut liver failure mortality from 60% to 10% and sharpens survival with proper HCC surveillance every 6 months. This page also tracks where iron lands beyond the liver, from diabetes in 30 to 50% of symptomatic patients to cardiac death driving 30% of mortality and mutation facts like C282Y accounting for 80 to 90% of hereditary hemochromatosis in Northern European populations.
Oral Herpes Statistics
Nearly 48% of US adults carry HSV 1 in the mouth and WHO estimates 3.7 billion people worldwide are infected, so cold sores are more about constant reactivation and intermittent shedding than a rare one time event. Find how fast oral antivirals can shorten healing and how PCR guided diagnosis clarifies risk, alongside market signals that the demand for treatment keeps rising.
Dwarfism Statistics
Achondroplasia is rare but demanding, with chronic pain reported by 12% of adults and ENT or airway events requiring clinical management in 61% of patients, alongside care use that can reach 7.0 to 10.2 encounters per year in U.S. Medicaid data. This page puts prevalence and incidence side by side with genetics, complications, and treatment response, from an estimated 1.1 per 10,000 births in France to 0.42 per 10,000 live births in Denmark, and highlights statistically significant growth gains in the vosoritide trial.
Birth Defects Statistics
Birth defects touch far more than you might expect, from 17.1% of infant deaths in 2020 and 52% of major congenital heart disease cases identified before birth to a striking prenatal pattern where folic acid use cuts anencephaly or spina bifida risk from 1.6% to 0.8%. See how specific exposures and conditions, like valproic acid and pregnancy diabetes, can measurably shift risk alongside prevention and screening rates that reveal exactly where outcomes are being caught early or missed.
Diabetes Global Statistics
From a $20.8 billion global diabetes care devices market to $125.7 billion across the wider diabetes care sector, Diabetes Global maps how spending on insulin, diagnostics, monitoring, and therapeutics is changing alongside real-world impact. It puts UK pressures and outcomes in focus, from 4.5 million diagnoses in England in 2023 to HbA1c benefits that cut complications and deaths, while trial results explain why some intensive approaches helped and others were stopped early.
Amyotrophic Lateral Sclerosis Statistics
ALS affects about 1 in 400 people across a lifetime, yet half of people die within roughly 3 years of symptom onset, while respiratory decline is often tracked with FVC thresholds like FVC under 80 percent predicted. You will also see how markers such as CSF NfL and functional scores like ALSFRS R help predict who progresses faster, alongside real world care and trial pipeline signals including tens of dollars per hour for home health aide support and ongoing U.S. recruitment on ClinicalTrials.gov.
Pnh Statistics
Fatigue hits 80 to 90 percent of people with PNH, yet the diagnostic signal can be surprisingly subtle with flow cytometry catching PNH RBCs under 1 percent while LDH climbs above 3 times the upper limit in 95 percent. See how modern complement control is changing outcomes with survival beyond 25 years on anti C5 therapy, thrombosis cut by 87 percent with eculizumab, and LDH dropping 85 to 90 percent within a week.
Gestational Diabetes Statistics
Gestational diabetes affects 6 to 9% of pregnancies in the US with over 200,000 cases each year and is not just a pregnancy glucose issue as it can raise preeclampsia risk 1.7 fold and make babies up to twice as likely to face neonatal hypoglycemia. It also shifts the future by carrying a 7.4 fold jump to type 2 diabetes within 5 to 10 years while today’s 24 to 28 week screening criteria and step by step treatment targets show how quickly mild cases can normalize with nutrition alone.
Fragile X Carrier Statistics
Fragile X premutation carriers face risks that can look surprisingly specific, from up to 40% of men over age 50 developing FXTAS to 8 to 10% of women often showing milder neuropathy and parkinsonism. This page also puts the carrier frequency and transmission math into context with 1 in 250 females and 1 in 800 males in the general population, plus how repeat instability can push 55 to 200 CGG alleles into full mutation in over 90% of transmissions.
Birth Trauma Statistics
Severe birth trauma can turn into lifelong outcomes fast, from cerebral palsy risk rising 10.2 times to brachial plexus deficits persisting for 5% of shoulder dystocia survivors. Updated with US and UK incidence figures from 2006 and 2012 and global neonatal death burdens, the page connects specific injuries like clavicle fracture and Erb palsy to their exact probabilities so you can see where prevention and early intervention change the odds.
Prader Willi Syndrome Statistics
From 95% of people develop hyperphagia between ages 2 and 8 to 99% diagnostic confirmation with methylation specific PCR, this page connects Prader Willi Syndrome symptoms to the tests and outcomes clinicians rely on. With prevalence around 1 in 10,000 to 30,000 live births worldwide and new hope from early growth hormone and multidisciplinary care, it turns genetics and hormone biology into practical expectations families can plan around.
Chronic Illness Statistics
In the United States, around 40% of adults now live with at least one chronic condition, and chronic diseases drive roughly 90% of the nation’s $4.1 trillion in annual healthcare spending. The same data set exposes stark gaps in who pays and who gets hit hardest, from diabetes and hypertension disparities to the real-world impact of treatments like statins and biologics.
Measles Statistics
Measles can move from exposure to rash in as little as 7 to 21 days, and the clues start early with Koplik spots appearing 1 to 2 days before the maculopapular rash. In 2022, the United States reported 121 confirmed cases across 16 jurisdictions while globally measles deaths reached an estimated 128,000 in 2021, mostly among children under 5, alongside complications like pneumonia in 5 to 10% of cases and encephalitis in about 1 per 1,000.
Clubfoot Statistics
From ultrasound detection after 18 weeks to Pirani and Dimeglio severity scoring, this page pulls together the 2025 ready clinical picture of clubfoot, including that Ponseti casting within two weeks and brace compliance over 90 percent leads to about 95 percent success. You will also see why relapse jumps to 30 percent when bracing drops under 50 percent, alongside striking global incidence differences up to 6.8 per 1,000 and a strong reminder that untreated clubfoot leaves half of adults with pain.
Genetic Disorders Statistics
Genetic disorders are a measurable burden and a growing industry at the same time, with $90.7 billion in global genetic testing projected for 2030 alongside an FDA linked companion diagnostic trend that reached 19% of oncology drug approvals in 2023. You will also see why detection is both promising and imperfect, from exome sequencing yields around 25% to 33% for rare disease and suspected genetic disorders to miscarriage risks and newborn screening false positives that help explain what happens after a single abnormal result.
Migraine Statistics
Migraine is the second leading cause of years lived with disability among neurological disorders yet remains badly underdiagnosed and undertreated, affecting about 1.4 million people with chronic migraine in the US. See how the burden translates into real costs and outcomes, from 8,400,000,000 dollars in US indirect losses and near two out of five people using acute meds too often, to the treatment response targets that can actually cut monthly migraine days.
Lead Poisoning Statistics
From 2011 to 2015 in the US, 3.6% of children ages 1 to 5 had blood lead levels of at least 5 µg/dL, and each 5 µg/dL increase is linked to about 3.9 IQ points lost while higher prenatal exposure can raise preterm birth risk 1.3 times. The page also tracks how lead paint bans, dust abatement, and water and air rules shift risk, plus why 1.5 million deaths worldwide each year are tied mainly to cardiovascular harm.
Pulmonary Fibrosis Statistics
With nearly 2.0 million IPF deaths recorded globally in 2019 alongside an annual UK estimate of 5,047 new cases, this page connects real incidence and survival realities to what changes in practice, including treatment patterns, functional decline, and cost and QALY value. Expect sharp contrasts such as antifibrotics linked to slower 6 minute walk deterioration and reduced FVC loss alongside guideline progression thresholds and multidisciplinary diagnosis habits that help explain why outcomes vary so widely.
Appendicitis Statistics
Appendicitis sits at the top of emergency abdominal surgery in the US, with about 23% of acute cases complicated by perforation, where children can stay 9.9 days in hospital versus 3.2 for non perforated disease. From CODA’s antibiotic first strategy to the surgery versus laparoscopy tradeoffs and APPAC’s 27% one year switch to appendectomy, this page connects what happens in practice to the outcomes that follow, including how appendicoliths and delayed treatment raise the odds.
Infertility Statistics
What does it really cost to try for a baby, and where does the money go when success rates are tight? From IVF cycles averaging $12,000 to $15,000 in the US and infertility treatment costs topping $30,000 for half of patients to global figures like 1 in 6 of reproductive age affected worldwide, you will see how factors like male issues, PCOS, and endometriosis shape outcomes and budgets, including an under-35 IVF live birth rate of 29.7% per cycle.